BAIAP2L1 and lung cancer: Oncogenic FGF receptor 3 (FGFR3)-BAIAP2L1 fusion gene was identified in bladder cancers [23] and lung cancers [24], and its identification may aid in selecting patients for FGFR-targeted therapy.